Australia markets open in 8 hours 26 minutes

Algorae Pharmaceuticals Limited (LVCLF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.0069+0.0028 (+68.29%)
At close: 09:30AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.25M
Enterprise value 9.86M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.07k
Price/book (mrq)4.86
Enterprise value/revenue 2.00k
Enterprise value/EBITDA -2.47

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 339.39%
S&P500 52-week change 326.14%
52-week high 30.0127
52-week low 30.0037
50-day moving average 30.0049
200-day moving average 30.0073

Share statistics

Avg vol (3-month) 31.65k
Avg vol (10-day) 3N/A
Shares outstanding 51.69B
Implied shares outstanding 61.78B
Float 81.05B
% held by insiders 140.59%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in AUD.

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,536.68%

Management effectiveness

Return on assets (ttm)-27.02%
Return on equity (ttm)-70.91%

Income statement

Revenue (ttm)42.02k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -1.49M
Net income avi to common (ttm)-2.25M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.62M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)26.81
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-1.84M
Levered free cash flow (ttm)-540.25k